News
A new dual vaccine for COVID-19 and flu shows strong immune responses and good safety in adults over 50, offering a potential ...
Canada does not currently have a bird flu vaccine, but research is underway at the University of Guelph to try and create an ...
Florida Surgeon General Joseph Ladapo will hold a news conference to address federal recommendations regarding COVID-19 vaccines for children on Thursday.
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.
New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory winning streak, which has also included nods for a next-gen COVID-19 vaccine ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results